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The interpretation and integration of epidemiological studies detecting weak associations (RR <2) with data from other
study designs (e.g., animal models and human intervention trials) is both challenging and vital for making science-based
dietary recommendations in the nutrition and food safety communities. The 2008 ILSI North America “Decision-Making
for Recommendations and Communication Based on Totality of Food-Related Research” workshop provided an overview of
epidemiological methods, and case-study examples of how weak associations have been incorporated into decision making
for nutritional recommendations. Based on the workshop presentations and dialogue among the participants, three clear
strategies were provided for the use of weak associations in informing nutritional recommendations for optimal health. First,
enable more effective integration of data from all sources through the use of genetic and nutritional biomarkers; second,
minimize the risk of bias and confounding through the adoption of rigorous quality-control standards, greater emphasis
on the replication of study results, and better integration of results from independent studies, perhaps using adaptive study
designs and Bayesian meta-analysis methods; and third, emphasize more effective and truthful communication to the public
about the evolving understanding of the often complex relationship between nutrition, lifestyle, and optimal health.
Keywords epidemiology, weak associations, dietary guidelines, decision making, communication, nutrition, Bayesian,
biomarker
INTRODUCTION
Population-based dietary guidance is faced with the con-
tinual challenge of appropriately considering the totality of
evidence, including preclinical, epidemiological, clinical, and
translational research. Nutritional epidemiology studies have
served as a vital signal of associations that sometimes point to the
need for additional investigations using animal models and/or
human intervention trials. Relative risk (RR) measurements less
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than 2.0, classified as “weak associations” in the broader field
of epidemiology, are common in nutritional epidemiology. In
some cases, conclusions about causality have been inappropri-
ately interpreted from such associations; in others, the results
have been completely dismissed.
Recognizing the important contribution that epidemiology
makes to nutrition science, as well as the need to explore av-
enues for reducing bias and confounding, the North Ameri-
can Branch of the International Life Sciences Institute (ILSI)
North America organized a 1997 workshop entitled “The Role
of Epidemiology in Determining When the Evidence Is Suffi-
cient to Support Nutrition Recommendations” (Byers, 1999).
The two-day workshop, held in Washington, DC, provided a
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forum for nutritional epidemiologists, nutritional scientists, and
food-policy experts from academia, industry, and government
to discuss the role of epidemiology in the formulation of dietary
advice for the public. The summary statement prepared by the
organizers briefly addressed the issue of weak associations in
nutritional epidemiology and concluded that: “The challenge,
then, is to distinguish the moderate effects that are real and have
important public health consequences from those that are arti-
facts. A change of 50% in risk (e.g., a relative risk of 1.5) may be
considered strong in nutritional epidemiology, so the commonly
cited criterion of relative risks < 2.0 being suspect does not nec-
essarily apply to nutritional epidemiology” (Byers et al., 1999).
Indeed, the relative risk of a nutritional exposure at a smaller
magnitude than is commonly seen in chemical toxicology may
have considerable potential for public health impact, because the
effect is multiplied by broad exposure within the population.
A decade later, ILSI North America revisited the subject
by convening the “Decision-Making for Recommendations
and Communication Based on Totality of Food-Related Re-
search” workshop in December 2008, in Washington DC. Par-
ticipants representing the nutrition and food safety communities
in academia, industry, and government shared current practices
in the interpretation of weak epidemiological associations, and
explored avenues for appropriate interpretation and integration
of animal study data, human intervention, and epidemiologi-
cal data in the development of public health recommendations
(Boffetta, 2008; Colditz, 2008; Ioannidis, 2008; Kris-Etherton;
2008; Liang, 2008; Livesey, 2008; Marantz, 2008; Picciano,
2008; Rowe, 2008; Russell, 2008; Schneeman, 2008; Squires,
2008; Wiseman, 2008). This report is a summary of the work-
shop dialogue, and does not necessarily reflect the opinions of all
of the members of the organizing committee or the presenters.
CONFERENCE SUMMARY
According to the widely accepted hierarchy of scientific evi-
dence, research along the continuum should lead to the random-
ized, controlled trial (RCT), with epidemiology and other types
of study considered as supportive of the RCT. However, the
perception of the RCT as the definitive research method is chal-
lenged by the prevalence of publication and reporting bias of
clinical studies. In an empirical investigation of the prevalence
of outcomes reporting bias in clinical investigations, Chan and
colleagues (2004) identified 274 RCT protocols approved by the
Scientific-Ethical Committees for Copenhagen and Frederiks-
berg, Denmark between 1994 and 1995; however, only 102 trials
resulted in one or more publications. A comparison of outcomes
reported in the resultant 122 published articles to those origi-
nally stated in the study protocols found that 50% of efficacy
and 65% of harm outcomes per trial were incompletely reported.
Furthermore, 86% of survey responders denied the existence of
unreported outcomes despite evidence to the contrary (Chan
et al., 2004). Although some may find Chan and colleagues’
assessment of the state of clinical trial reporting difficult to ac-
cept for a variety of reasons, these results should be seen less
as an indictment of RCTs as a whole but more as a sobering
recognition that wholesale acceptance of the conclusions of a
study simply because it uses randomization and placebo con-
trols may not always be warranted. RCTs can be as flawed as
any other study design. Extrapolation of results from a single
RCT to form conclusions beyond the controlled conditions of
the RCT, perhaps to refute an association observed in one or
more observational studies, may not give the truest picture of
the biology underlying a perceived association. As discussed
in later sections of the current report, the true association may
be better discerned by combining multiple independent lines of
evidence, such as RCTs, epidemiology, and data from model
systems. Laboratory studies using appropriate model systems
are essential for the study of metabolic pathways and mecha-
nisms of action at the cellular or organ level; clinical studies
are well suited to answer questions about a specific intervention
in a defined population over a limited span of time; and epi-
demiology is better suited to address questions about a broader
population over several years or decades. Interventional studies
present an opportunity to examine whether a change in behavior
can produce the same benefit as persistent behavior in observa-
tional studies. These three fields of study each provide a portion
of the true health impact of nutrients on overall health. To para-
phrase British mathematician, logician, and philosopher Alfred
North Whitehead (1861–1947), in nutrition research there are
no whole truths; all truths are half-truths. It is trying to treat them
as whole truths that plays the devil (Whitehead, date unknown).
A. Bradford Hill’s (Hill, 1965) criteria for inferring causality
provide a means for judging the merit of an association between
food or nutrient intake and a health outcome. The durable use-
fulness of these criteria is in the explicit acknowledgment that
no one line of evidence is sufficient to infer a causal relationship.
Rather, it is in examining the totality of the currently available
data (from biological model systems, clinical intervention trials,
and epidemiology) that one can, until new and better evidence
comes to light, infer a causal association.
Epidemiological Methods and Applications: An Overview
The appropriate interpretation of weak associations is
an important aspect of epidemiology, and is particularly
challenging in nutrition. Although there is no sharp delineation
between strong or weak effects, “strong associations” tend to
be viewed as being more suggestive of a causal relation than
“moderate” or “weak” associations. Weak associations are
more likely to be perceived simply as the result of chance or the
play of uncontrolled sources of systematic error. Discerning the
true association between nutrient intake or dietary pattern and
a health outcome may be complicated by bias or confounding
effects. One particular challenge in nutritional epidemiology
is that there are essentially no completely treatment-naı¨ve
subjects with respect to diet or lifestyle. Therefore, investigators
can only compare high and low exposures when evaluating
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health benefits. Particularly in the case of chronic diseases
with long latency, the study design must reflect whether the
nutrient or lifestyle exposure is being considered in terms of
primary versus secondary prevention, because the two are not
interchangeable (Boffetta, 2008; Colditz, 2008).
Differences in study methodology and design contribute to
variability in the overall body of evidence. Conversely, study
design and methodology can be used to limit the effects of
bias and confounding in the study of weak associations. One
way to increase the ability to detect small effects, as well as
to reduce recall bias, is to use a prospective study design with
repeated measures. Replicating studies in different populations
can help to confirm or refute the finding of a weak association.
Along these lines, the formation of research consortia could
enable concurrent planning of smaller studies with compatible
designs. Using this approach would allow results to be more eas-
ily compared. Large international research consortia, requiring
public deposition of data and deliberate steps to avoid selective
reporting of data, would also minimize the risk of bias. Simi-
lar consortia have been implemented over the past 10 years in
genetic epidemiology. The most important potential advantage
to nutritional epidemiology would be the replication of results
(Ioannidis, 2008).
Bayesian inference methods may be well adapted to the anal-
ysis of data from multiple independent studies, in contrast to the
current reliance on statistical significance of individual studies.
Provocative new data may trigger a so-called bandwagon effect
in which a series of publications favoring one outcome beget
other articles with like outcomes, although sometimes with pro-
gressively weaker associations. Once data have been published
in the literature, there is a resistance to refutation by subsequent
studies. Even discredited associations tend to be resurrected
periodically by “new statistically significant” results. Statistical
significance may be less important with respect to weak associa-
tions, and may be more practically replaced by the Bayes Factor
(Goodman, 1999) as a measure of probability of an effect. The
Bayes Factor may in fact enable investigators and policy makers
alike to make the best use of present and accumulating data on
weak associations.
Applications of Epidemiological Data for Decision Making:
Discerning the Link
It is important to understand the difference between the con-
siderations of acute toxic exposures and long-term chronic ex-
posures. The use of epidemiological methods in tracking down
foodborne disease outbreaks is an example of acute exposures
where the cost of inaction to human health can be so great that
decisions must be made, even if causal relations are difficult
to establish (Liang, 2008). Food safety outbreaks tend to show
very strong but imprecise RRs because the number of individu-
als affected is usually small. The Salmonella outbreak in peanut
products that began in 2007 (Centers for Disease Control and
Prevention (CDC), 2007) illustrates how epidemiological meth-
ods were applied to identify the cause of illness and issue public
health alerts. Causal links between food and acute illness are
inferred from an integration of epidemiologic data, laboratory
work, and the judgment of public health professionals. Such
investigations can still be challenged by incomplete data (e.g.,
the source of contamination may be eradicated, intentionally or
unintentionally, before investigators can get to it; or cases or
controls may be reluctant to participate for a variety of reasons).
Long-term health consequences present a particularly diffi-
cult challenge to the epidemiologist. Whereas foodborne dis-
ease outbreaks typically identify strong associations when close
to the source, dietary patterns assert subtle effects on health
outcomes such as cancer only with prolonged exposure. Fur-
thermore, there are multiple contributions to chronic health out-
comes, including genomic and lifestyle confounders. Therefore,
asserting that a particular quality of dietary exposure causes a
health outcome is exceedingly difficult.
The evolution of U.S. Food and Drug Administration (FDA)
regulation of food and dietary supplement labeling regarding
such claims demonstrates the challenge of balancing the right
of the consumer to accurate health-related information with pro-
tecting them from misleading information or harmful products.
From the Nutrition Labeling and Education Act of 1990 (NLEA,
1990) to qualified health claims in the 1990s, the heart of the
controversy lies in defining the type of evidence that will be
accepted in establishing a credible link between the intake of
a nutrient and a health outcome. For health claims to appear
on a food label without caveat regarding the level of evidence
backing the statement, the FDA has retained the standard of
significant scientific agreement with respect to the relevant nu-
trient and “disease or health-related condition.” A systematic
evaluation of published intervention and observational studies
in humans considers the strength of the evidence in terms of
study design, methodological quality, study sample sizes, rel-
evance to the target population, replication of results, and the
quantity and overall consistency of the evidence (FDA, 2009).
Forming Dietary Recommendations for the Public
The adoption of evidence-based decision making in public
health recommendations was intended to move the profession
away from reliance on “expert opinion” and toward considera-
tion of the sum of evidence. However, the demand for guidance,
even in the face of weak associations and incomplete data, can be
considerably challenging to regulators and expert panels dealing
in the public health arena.
For example, a recent analysis of data on the relationships
between intakes of particular foods and the risk for cancer re-
vealed that most were weak (RR <2.0), and were judged by
the expert panel to understate the true effects (Wiseman, 2008).
Because these were the best available data at the time, the panel
made dietary recommendations that they judged to be consistent
with helping to reduce the incidence of cancers. In such cases,
the need for subsequent monitoring and evaluation of the impact
of such recommendations is important.
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The evidence standards for dietary guidelines should appro-
priately be as high as or higher than for pharmaceuticals be-
cause of the large numbers of people, including children, who
are affected by the recommendations. Pointing to the case of
recommendations in the 1990s to reduce fat intake to less than
30% of one’s daily calories, it was not anticipated that dietary
choices that were intended to reduce fat would translate into
higher carbohydrate and calorie intakes. During the period from
1980 to 2000, fat intake as a percentage of calories declined.
However, energy intake and carbohydrates as a percentage of
calories increased significantly (CDC, 2004), and at the same
time, the incidences of obesity (Flegal et al., 2002) and dia-
betes also increased (CDC, 2008; Cowie et al., 2009; Engelgau
et al., 2004). Dietary recommendations can have unintended ef-
fects; the imperative should be, “first, do no harm.” Published
dietary recommendations tend to persist in the public domain as
entrenched eating habits and commercially available prepared
foods, even when superseded by new recommendations. An ap-
propriate level of conservatism seems prudent when making
such recommendations.
Whether the public has a fundamental (ethical, legal, or
moral) right to health information, even if it is incomplete, to
be able to make personal decisions is an ethical issue that can-
not be dismissed. A decision to make, or withhold from mak-
ing, a recommendation can have public health consequences
for good or ill. Dietary recommendations are intended to in-
form the public about the best current understanding of food
choices to support good nutrition and good health, but may also
be used to provide nutritionally balanced meals for individuals
who cannot make autonomous, informed decisions about food
choices.
For example, some have questioned the current practice of
revisiting the U.S. Dietary Guidelines for Americans every five
years. A three-step process has been proposed and comprises
a technical advisory committee that would provide the scien-
tific rationale for the recommendations; a users’ committee that
would review the recommendations for economic, commercial,
and public health impacts; and a federal dietary guidelines com-
mittee that would formulate the recommendations. Advocates of
this approach argue that it would provide a staged forum for vet-
ting possible unintended consequences from recommendations
(King, 2007).
Using epidemiology alone to define dietary reference in-
takes (DRI) would be problematic, in that such reference values
target risk reduction for a particular chronic disease (Russell,
2008). Although observational studies can provide valuable sup-
port in establishing links between nutrient intakes and risk for
chronic diseases, they are of limited value alone in establish-
ing causality. Because the development of chronic disease can
have a long latency, the selection of suitable surrogate mark-
ers is critical to the usefulness of observational and clinical
studies of limited duration. It is also important to integrate find-
ings from different types of studies that use similar biomarkers,
as well as from systematic reviews and meta-analyses of such
studies.
Recent and Emerging Issues
Three examples of the interpretation of weak associations in
nutritional epidemiology include—vitamin D supplementation
for optimal health (Picciano, 2008), the health effects of fruc-
tose intake (Livesey, 2008), and the cardiovascular effects of an
incidental component of partially hydrogenated oils, trans fat
(Kris-Etherton, 2008).
Vitamin D status has been linked to a reduced risk for some
types of cancer, cardiovascular disease, diabetes, osteoporosis,
and other chronic diseases; however, the data are highly variable
in some cases. Increased awareness of widespread vitamin D in-
sufficiency may well result in significant increases in vitamin D
intakes beyond the recommended levels, and thus in a potential
increase in cases of vitamin D toxicity from over supplementa-
tion. There is currently little scientific agreement on what can be
considered an “optimal” intake of vitamin D, although accumu-
lating evidence supports the need for supplementation for some
individuals (Mithal, 2009). To address these issues, the Institute
of Medicine has convened a group of experts to re-evaluate the
vitamin D and calcium DRIs.
The analysis of fructose-intake data illustrates the potential
for both the use and misuse of weak associations in epidemio-
logical data. It is effectively impossible to tease out the specific
effect of fructose in the diet because it is typically consumed
on a nearly equimolar basis with glucose (e.g., as sucrose, or
as a mixture in high-fructose corn syrup). Other confounders
may include lower magnesium intake, reduced fiber intake, and
less physical activity coincident with increasing energy intake.
It may be that fructose intake is actually a marker for some other
dietary pattern, such as excessive carbohydrate intake, or a com-
bination of factors, rather than the causative agent. The public
health risk associated with misattributing the rise in incidence
in diabetes to overconsumption of a single dietary component
highlights the lack of attention being paid to other factors that are
associated with the increasing incidence of obesity, particularly
among the young.
The story of trans fats and the risk for coronary heart disease
is a success story for the use of epidemiology in identifying
a public health risk and guiding well-designed clinical studies
to establish a clear causal link. The current recommendation to
avoid trans fats is based on more than 15 years of supporting
epidemiological and clinical research. The story is presently
evolving as ongoing research investigates other possible causal
links between the intake of trans fats and the risk for diabetes
and other chronic diseases.
CRITICAL EVALUATION OF TOTALITY OF DATA AND
PERSPECTIVES: TOWARD A POSITION STATEMENT
Opportunities and Challenges
The ILSI North America workshop, both the presenta-
tions summarized above and the dialogue among participants,
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provided three clear strategies for understanding weak associa-
tions in nutritional epidemiology:
1. Enable more effective integration of data from all sources
through the development and use of robust nutritional and
genetic biomarkers;
2. Minimize the risk of bias and confounding through the adop-
tion of rigorous quality-control standards, greater emphasis
on replication of study results, and integration of results from
independent studies, possibly using adaptive study designs
and Bayesian meta-analysis methods; and
3. Emphasize effective communication of study results to the
public in relation to existing knowledge across the spectrum
of research design, and to the public health significance of
the results.
Integrate Data from All Sources
The interactions of genetics, nutrition, and lifestyle over a
lifetime is complex and beyond the scope of any one study
design. In an article published more than a decade ago in the
American Journal of Clinical Nutrition, Gladys Block (1995)
provided the following summary:
“We would like to answer the following questions regarding health and
disease. 1) Can we cure a disease? 2) Can we modify the course of a
disease? 3) Can we prevent a disease? The first two important questions
can be studied well with clinical trials. However, the third question is
the one at issue here. In the context of dietary factors, we would like to
know whether by eating a certain way throughout our life or consuming
certain nutrients we can reduce our risk for disease. This is a question
. . . that clinical trials are not suited to answer.”
The logistical reasons for this are mainly cost, compliance, and
duration. For this reason, epidemiology can be an effective tool
in addressing questions related to disease prevention and risk
reduction, but is by no means the only tool; RCTs are another
tool, but can be more difficult to use in long-term studies. The
most effective use of study data is not to treat each study as
a separate event, but to treat them collectively as pieces in the
complex puzzle of nutrition and health. No single line of experi-
mental evidence can illuminate every aspect of a causal relation-
ship. Rather, the study of complex nutrient–health interactions
demands the integration of both various effective, although lim-
ited, experimental approaches and multiple lines of evidence.
Integration of study results may be greatly facilitated by using
similar outcomes measured by compatible instruments that are
comparable across various studies.
The Bradford-Hill criteria may be misused if these are em-
ployed as a “checklist for causal criteria” (Ho¨fler, 2005). Rather,
these criteria emphasize the imperative of including data from
multiple lines of evidence, particularly studies that delve into
the biological plausibility of an association. The importance of
preclinical research is hard to overemphasize, but in an environ-
ment in which the formation of health policy recommendations
tends to exclude studies in model systems, an integral element
of the totality of the data may frequently be ignored.
Nutritional Biomarkers
Two commonly used methods to assess nutritional status
include dietary recall, typically using food frequency question-
naires (FFQ), or measurement of biomarkers for nutritional sta-
tus. Several FFQ are available to investigators to use as a tool
for assessing the frequency and amount of nutrient intake. Val-
idated FFQ are designed for a specific population or to look for
specific items, and are not necessarily suitable for every new
circumstance. An appropriate validation will typically evaluate
whether the FFQ provides results that are consistent with other,
more rigorous methods of measuring food intake, but usually
not against an objective biochemical indicator or intake for most
nutrients. Investigators must consider if the FFQ was designed
to assess the dietary substance that is of interest for a possible
health claim and whether it is validated to predict the food intake
of interest.
Changes in nutritional biomarkers of exposure in blood,
urine, or other tissues can help elucidate biological effects of nu-
trient intakes, independently or jointly with dietary recall data,
and enhance interpretation of observational study results. Nu-
tritional biomarkers may also further enable researchers to re-
late results from observational studies to those of interventional
studies. Certain challenges will remain, including the need for
methods to reliably assess the nutritional status of an individual
and to measure the true range of intakes in the study, regardless
of the study design.
Genetic Markers
Nutrient–gene interactions may be grouped into three cate-
gories: 1) direct interactions, wherein a nutrient directly affects
gene expression; 2) epigenetic interactions, in which nutrients
act to chronically alter gene expression; and 3) genetic varia-
tions that can affect the structure or function of a protein product
or whether a protein is produced (Zeisel, 2007). The latter cate-
gory is of particular importance to the design and interpretation
of population studies and the understanding of the real impor-
tance of small effects. Human genetic variability is such that a
given exposure to a nutrient may present no measurable health
effects in one part of the population, but can elicit a significant
decrease or increase in disease risk in a different genetic popula-
tion. These differences profoundly complicate policy decisions
regarding nutrient intakes.
Nutritional studies tend to focus on comparing extremes
of exposure or nutrient intake partly because differences at
an acceptable level of significance can be easier to detect when
comparing the highest versus the lowest intakes. Even when
studying intake extremes, associations may be very strong in
some cases and weak in others. What is the effect of comparing
extremes on the dose-response curve? Should policy makers
make recommendations for the general population, in which
intakes may predominately fall in the middle range, on the
basis of data that represent extremes?
Replication of studies of various populations provides an em-
pirical solution to the study of nutrition and health in various
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genotypes. Rather than seeking to diversify the study popula-
tion in each study, would designing smaller studies with more
homogenous study populations and replicating them in various
geographic areas be more effective?
Minimize Bias and Confounding
The complexity of interacting effects in free-living humans
among genetics, lifestyle, and nutrition (e.g., quality of the diet
and history of intake) can result in serious confounding effects.
For example, these effects may be illustrated by studies of vita-
min D and various health outcomes, in which intake is assessed
by dietary recall or supplementation without measuring serum
vitamin D levels. Such studies may fail to detect significant pro-
tective benefits compared with studies that implicitly consider
the contribution from photosynthesis (related to age, ethnicity,
lifestyle, geography, and season) by measuring serum levels.
The interaction of nutrition and lifestyle has been well stud-
ied for several decades and has provided enormous dividends
in improving both health and longevity, notwithstanding the ac-
celerating increase in obesity and diabetes worldwide. Many
diseases related to malnutrition have been eliminated in most
developed and many developing countries, and efforts continue
to address these diseases effectively in the regions in which they
still occur. Great progress has also been made in the past 10
years in the area of human genomics and metabolomics. More
and better tools are needed for the study of nutrient–gene inter-
actions in laboratory systems, clinical trials, and observational
studies to allow a more complete picture to emerge of how good
nutrition can best support good health. Such advances offer great
promise in reducing confounding.
Statistical significance is important when evaluating associ-
ations, with some caveats. The size of the study population is
among the factors that contribute to a lower P value. Should an
association be discounted because the study is underpowered to
find a statistically significant effect? Conversely, statistical sig-
nificance is commonly held to be a requisite, but is not sufficient
alone to either establish a link or to discount the possibility of
bias. All studies are susceptible to bias. Can several studies that
are all susceptible to a similar source of bias, most of which
with results that do not reach the level of statistical significance
(0.05 < P < 0.1), be credibly combined to provide the addi-
tional power needed for statistical significance? In addition to
the adoption of strict quality-control measures, better methods
for data analysis are needed to effectively combine results from
multiple studies.
The scientific method is essentially a process for conducting
systematic observation and testing a new prediction (hypothesis)
consistent with the observation. Clinical investigators and epi-
demiologists alike often find a situation in which they discern a
pattern or trend in the data that is suggestive, but not statistically
significant. There are two commonly used statistical approaches
to treat the data: classical and Bayesian inference. Classical in-
ference is the more common approach, using hypothesis testing
and statistical significance to accept or reject a null hypothesis
that implicitly encompasses external information. Weak associ-
ations and small effects, assuming they are plausible and sup-
ported by laboratory studies, present a particular difficulty to
classical inference methods. Large studies may be better able to
detect associations of small to moderate size, but a larger group
of study participants (N ) also risks overpowering the study to
detect more false-positive associations.
Bayesian inference accepts external scientific information as
a prior distribution. The usefulness of Bayesian meta-analysis
is illustrated in a recent analysis by Berry et al. (2009), which
was composed of several publications that examined vitamin E
supplementation and mortality. Two previous analyses found an
increase in all-cause mortality associated with vitamin E sup-
plementation (Bjelakovic et al., 2007; Miller et al., 2005). Berry
et al. (2009) included the same articles that were cited in Miller
et al. (2005) and used Bayesian hierarchical-model averaging
to combine data from the studies that met the inclusion crite-
ria and Markov chain Monte Carlo computational techniques
for the analyses. Unlike the previous meta-analyses (Bjelakovic
et al., 2007; Miller et al., 2005), the Bayesian analysis showed
no association between vitamin E supplementation and all-cause
mortality, regardless of the dose (Berry et al., 2009). The im-
plications of this difference are considerable and merit further
attention.
Communication
Because assertions regarding dietary effects on health, or the
lack thereof, can considerably impact public health, the manner
in which they are communicated to the consumer has been the
subject of controversy for almost two decades. Great empha-
sis is currently placed on developing health policies, including
dietary guidelines (King, 2007), using an evidence-based ap-
proach. There are two components to this process: 1) conducting
the research to provide the evidence, and 2) communicating the
science to enable informed decision making. Nutrition and food
safety decisions are no better than the quality of the science and
the related communications.
The communication of study results can be complicated by
terse or incomplete reporting of the statistical methods and mod-
els used in the analysis of study results. Authors may seem
to arbitrarily select a method of assessing and evaluating di-
etary data, and apply various corrections. Statements noting
that something was “adjusted for energy intake,” for example,
may leave the reader to speculate about how and why the adjust-
ment was made. Indeed, authors face a difficult choice between
providing details and complying with a publication’s tight word
limit. Complete reporting of mathematical and statistical terms
and models is important, and can be provided in supplementary
documents if not in the full article.
Although statistical methods can be difficult for the pro-
fessional, they are all the more confusing to a lay reader. For
example, epidemiology has historically used odds ratios (ORs)
or RRs as a measure of association between exposure (e.g., to
a nutrient) and a health effect across retrospective, case-control
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studies and prospective cohort studies. Some researchers report
the attributable risk or population-attributable risk as a measure
of attribution of disease to a given nutritional exposure or defi-
ciency. Public media reporting on health research can serve its
readers well by not only accurately reporting risk, but also by
explaining the meanings and nuances of these various statistical
methods.
When the results of the Women’s Health Initiative study of
the effects of low-fat dietary patterns on the risk for breast can-
cer (Prentice et al., 2006) and cardiovascular disease (Howard
et al., 2006) was reported in the New York Times online edi-
tion (Kolata, 2006), the first line in the article announced: “The
largest study ever to ask whether a low-fat diet reduces the
risk of getting cancer or heart disease has found that diet has
no effect.” The article ignored many other findings that sup-
port health benefits from a low-fat diet and the fact that most
participants did not reduce their dietary fat to the target level.
Rather than focus on accurately reporting the complete results
in the scientific publication, the article quoted several selected
opinion leaders as if the scientific merit of the study could be
determined by popular vote. If epidemiologists are to be crit-
icized for not presenting results in a more accessible manner,
the media may well be criticized for grossly oversimplifying for
the public the complex interactions between diet, lifestyle, and
genetics. The nutrition research community understands the lim-
itations of a given finding, but the public listens for answers and
makes decisions on the basis of single studies. With food news
in the headlines daily, consumers are at risk of ignoring useful
health advice and adopting unhealthful or ineffective dietary
changes.
Another aspect of informed decision making involves the
ethical and political aspects of nutritional recommendations.
These are areas outside of scientific methodology, but neverthe-
less profoundly affect the credibility of the science, regardless
of how unimpeachable the methodology. Refraining from mak-
ing a recommendation because of inconclusive evidence may
be interpreted as a recommendation in itself (i.e., a decision
to perpetuate current practice), which carries its own inherent
ethical and health-related consequences. Finally, the integrity
of even the soundest science will surely be called into ques-
tion if the funding is considered to be from a biased or partisan
source, such as industry, or the study seems to be politically mo-
tivated. Forming research consortia, perhaps comprising inves-
tigators from industry, government, and academia, and sharing
responsibility for the analysis and communication of the results
from nutrition research may enable clearer understanding of
experimental results, and effective communication of nutrition
recommendations.
SUMMARY
In summary, it is important to consider the totality of data in
decision making. Studying nutrition is different from studying
drugs. There are challenges unique to nutrition studies, including
the complexity of different types of diets and subtle differences
among various nutrients and among individuals, both of which
are multiplied when addressing a chronic health outcome. Bet-
ter integration and critical evaluation of all data, including pre-
clinical, epidemiology, and RCTs, can be accomplished in part
through efforts to improve research standards for all study types,
such as improved outcomes reporting, as well as collaboration
to facilitate comparability and replication through study design
and the use of nutritional biomarkers and genetic information.
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